Report Details
Visiongain have the pleasure of announcing the latest edition of their industry leading report - The World OTC Pharmaceutical Market, 2008-2023. This edition updates the world OTC market at present and predicts its sales revenues and trends from 2008-2023, including drivers and restraints on the market. Sources used include industrial databases, commercial and financial news, published reports and policy documents, interviews and questionnaires. Visiongain applied financial forecasting, qualitative analyses and the assessment of unmet needs to provide a comprehensive market-based report with detailed analysis and informed opinion. The report examines the worldwide OTC market, breaking down present and forecasted sales revenues into leading therapeutic categories and national markets. Visiongain also provides forecasts for leading OTC brands.
In particular, this report concentrates on the following essential aspects of the global OTC industry:
• Major therapeutic areas treated by OTC products
• Key industrial players in the OTC market
• Financial forecasts covering the period 2008-2023, including leading brands, countries and therapeutic areas
• Geographical breakdown of the market
• Sales of the highest-selling OTC brands and other relevant information
• Coverage of prescription-only to OTC switching in the pharma industry
Why you should buy this report:
• To receive a comprehensive analysis of the prospects for the OTC industry from 2008-2023, including sales by therapeutic area and country
• To discover predicted revenues, growth rates and other key metrics for OTC pharmaceuticals from 2008-2023, including those of leading brands
• To discover possible future OTC switching candidates
• To determine the forces that influence the OTC market:
• Drivers and restraints on market
• Competition
• Strengths, weaknesses, opportunities and threats
Visiongain forecasts that OTC pharmaceutical sales will almost double from 2007 levels by 2023. In the period 2008-2023, the worldwide OTC market will undergo a period of dynamic change. Increasingly aging populations and rising incidence of lifestyle diseases, as well as the need to reduce healthcare costs, will open up new therapeutic areas for OTC switching. Likewise, sales of existing OTC products will rise. At the same time, changes in retail patterns and new ways of advertising will open up access to OTC drugs to a public better educated and more interested in self-medication than at any previous time. Taking advantage of such opportunities will take considerable skill in a crowded and competitive marketplace. Consequently, the commercial prospects are very good for companies well placed to serve those growing needs. In these difficult times for the global pharmaceutical industry, OTC sales will become increasingly important, visiongain concludes.
Table of Contents
1 Executive Summary
2 Introduction to OTC Pharmaceuticals
2.1 Over-the-Counter or Behind-the-Counter: What are OTC Pharmaceuticals?
2.2 Key Features of OTC Pharmaceuticals
2.3OTC Switching
2.4 Manufacture and Distribution of OTC Pharmaceuticals
2.5 Regulation of OTC Pharmaceuticals
2.5.1 United States
2.5.2 Japan
2.5.3 European Union
2.5.4 Other Countries
2.6 Major Therapeutic Areas for OTC Pharmaceuticals
2.6.1 Analgesics
2.6.1.1 Internal Analgesics
2.6.1.2 External Analgesics
2.6.2 Cough, Cold, and Allergy Products
2.6.3 Gastrointestinal Products
2.6.4 Medicated Skincare Products
2.6.4.1 Minor Cuts and Wounds
2.6.4.2 Acne
2.6.4.3 Rashes, Itchy Skin, Dermatitis and Eczema
2.6.4.4 Cold Sores
2.6.4.5 Warts
2.6.4.6 Fungal Skin Infections
2.6.4.7 Haemorrhoids
2.6.4.8 Other Medicated Skincare Products
2.6.5 Vitamins, Minerals & Supplements
2.6.6 Other OTC Pharmaceuticals
3 The Global OTC Pharmaceutical Market
3.1 The World Market for OTC Pharmaceuticals Will Almost Double in Size by 2023
3.2 Which are the Largest OTC Therapeutic Categories?
3.3 The Leading Global OTC Pharmaceutical Manufacturers
3.3.1 Johnson & Johnson
3.3.2 Bayer
3.3.3 GSK
3.3.4 Novartis
3.3.5 Wyeth
3.4 The Leading World OTC Brands
3.4.1 Tylenol is the Only Global Billion Dollar OTC Brand
3.4.2 Claritin Will Loose Its Dominant OTC Market Position
3.4.3 Prilosec OTC Will Face Competition from Generics and New OTC Switches
3.5 The OTC Market is Rapidly Changing
4 SWOT Analysis of the OTC Pharmaceutical Industry
4.1 SWOT Chart
4.2 OTC Switching
4.3 Changing World Demographics
4.4 Developments in Wholesale and Retail Channels
4.5 Brand Identity and Private Labels
4.6 Will OTC Move Behind-the-Counter?
4.7 New Advertising Opportunities
4.8 Safety Concerns Over Misuse and Abuse of OTC Pharmaceuticals
5 The OTC Pharmaceutical Market by Geographical Area
5.1 The World OTC Market: China and India Will Increase Their Market Share
5.2 The US OTC Market
5.2.1 The US OTC market in 2007
5.2.2 The US OTC Market 2008-2013
5.3 The Japanese OTC Market
5.3.1 The Japanese OTC Market in 2007
5.3.2 Leading Japanese OTC Pharmaceutical Companies
5.3.2.1 Taisho
5.3.2.2 Takeda
5.3.2.3 Daiichi Sankyo
5.3.2.4 Lion
5.3.3 The Japanese OTC Market 2008-2013
5.4 The European OTC Market
5.4.1 The European OTC Market in 2007
5.4.2 The European OTC market 2008-2013
6 Prescription-Only to OTC Switching
6.1 Recent Switching Activity
6.2 Gastrointestinal OTC Switching
6.3 Cough, Cold and Allergy OTC Switching
6.4 Analgesic OTC Switching
6.5 Medicated Skincare OTC Switching
6.6 Cholesterol-Lowering OTC Switching
6.7 Erectile Dysfunction OTC Switching
6.8 OTC Switching: A Continuing Trend in 2008-2023
7 Conclusions
List of Tables
Table 3.1 World Sales Forecast ($bn) for OTC Pharmaceuticals 2006-2023
Table 3.2 World Sales ($bn) for OTC Pharmaceuticals by Therapeutic Class 2007
Table 3.3 World OTC Sales Forecast ($bn) by Therapeutic Category 2006-2023
Table 3.4 Sales ($bn) of Top Five World OTC Manufacturing Companies 2007
Table 3.5 Tylenol Worldwide Sales Forecast ($bn) 2007-2023
Table 3.6 Claritin (OTC) Worldwide Sales Forecast ($bn) 2007-2023
Table 3.7 Prilosec OTC Worldwide Sales Forecast ($bn) 2007-2023
Table 4.1 SWOT Chart for the OTC Pharmaceutical Industry
Table 4.2 World Population 2007-2023
Table 4.3 China, India, US & Japan Population 2007-2023
Table 4.4 GDP ($tr) US, Japan, China & India 2007-2023
Table 5.1 OTC Pharmaceutical Sales by Country 2007
Table 5.2 OTC Share of Pharma Market by Country 2007
Table 5.3 Forecast World Sales ($bn) of OTC Pharmaceuticals by Country 2007-2023
Table 5.4 OTC Therapeutic Areas US 2007
Table 5.5 Largest selling OTC Pharmaceutical Brands in the US 2007
Table 5.6 Sales ($m) of alli in the US 2007-2013
Table 5.7 OTC Therapeutic Areas in Japan 2006
Table 5.8 Leading Japanese OTC Manufacturing Companies 2006-07
Table 5.9 Leading Cough, Cold and Allergy Brands in Japan 2008-2013
Table 5.10 Sample European OTC Country Markets 2007
Table 5.11 OTC Therapeutic Areas in Europe 2007
Table 6.1 Selected Recent Prescription-Only to OTC Switches
Table 6.2 Selected Possible Future OTC Switches
Table 7.1 Leading OTC Country Markets 2007 & 2023
List of Figures
Figure 1.1 World Sales Forecast ($bn) for OTC Pharmaceuticals 2007-2023
Figure 2.1 The OTC Pharmaceutical Supply Chain
Figure 3.1 World Sales Forecast ($bn) for OTC Pharmaceuticals 2007-2023
Figure 3.2 World Sales Forecast ($bn) for Pharmaceuticals 2007-2023
Figure 3.3 World OTC Sales Forecast ($bn) by Therapeutic Category 2007-2023
Figure 3.4 Share of World OTC Pharmaceutical Sales by Therapeutic Category 2007
Figure 3.5 Forecast Share of World OTC Sales by Therapeutic Category 2013
Figure 3.6 Forecast Share of World OTC Sales by Therapeutic Category 2018
Figure 3.7 Forecast Share of World OTC Sales by Therapeutic Category 2023
Figure 3.8 Sales ($bn) of Top Five World OTC Manufacturing Companies 2007
Figure 3.9 Tylenol, Prilosec OTC and Claritin (OTC) World Sales Forecast 2007-2023
Figure 4.1 Populations of US, Japan, China and India 2007-2023
Figure 4.2 Population Aged 65 or Over in US, Japan, China and India 2007-2023
Figure 4.3 Populations % Aged 65 or Over in US, Japan, China and India 2007-2023
Figure 4.4 Gross Domestic Product ($tr) for US, Japan, China and India 2007-2023
Figure 5.1 Forecast Sales ($bn) of OTC Pharmaceuticals by Country 2007-2023
Figure 5.2 Forecast Sales ($bn) of OTC Pharmaceutical by Country 2007-2023
Figure 5.3 Market Share of World OTC Pharmaceutical Sales by Country 2007
Figure 5.4 Forecast Market Share of World OTC Pharmaceuticals Sales by Country 2013
Figure 5.5 Forecast Market Share of World OTC Pharmaceuticals Sales by Country 2018
Figure 5.6 Forecast Market Share of World OTC Pharmaceuticals Sales by Country 2023
Figure 5.7 Sales ($m) of alli in the US 2007-2013
Figure 5.8 Leading Japanese OTC Pharmaceutical Companies 2006-07
Figure 5.9 Leading Cough, Cold and Allergy Brands in Japan 2008-2013
Companies Listed
AmerisourceBergen
Abbott Laboratories
Adams Respiratory
Alliance Boots
AstraZeneca
Barr
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Cardinal Health
Celesio
Chattem
CNS
Daiichi Sankyo
Dr.Reddy's
Eisai
European Medicines Agency (EMEA)
Food and Drug Administration (FDA)
GlaxoSmithKline (GSK)
Johnson & Johnson
Kowa
Lion
McKesson
Medicines and Healthcare products Regulatory Agency (MHRA) (formerly MCA, (Medicines Control Agency))
Menarini
Merck & Co.
Ministry of Health, Labour and Welfare (MHLW)
Mission Pharmacal
Novartis
Perrigo
Pfizer
Phoenix Group
Proctor & Gamble
Ranbaxy
Reckitt Benckiser
Roche
Rohto
Sanofi-Aventis
Santarus
Sato
Schering-Plough
SSP
Taisho
Takeda
TAP
Target
Teva
Wal-Mart Stores
Wyeth
Zepharma